|1825 Connecticut Ave NW, Suite 400 , Washington, DC 20009|
|Fund Manager||Ian Kirwan|
|Manager Tenure||4 Years 10 Months|
The Fund's investment objective is to seek long term capital appreciation by investing primarily in equity securities of companies located in emerging market countries. The Fund normally invests at least 80% of its assets, including borrowings for investment purposes, in equity securities of companies located in emerging market countries (the 80% Policy). The Fund is sub advised by Hermes Investment Management Limited (the Sub Adviser). Equity securities held by the Fund will primarily include common stock, preferred stock, depositary receipts, options on securities, and equity equivalent securities, such as participation notes (P Notes). Derivatives, such as futures, options on futures, and swaps, may also be held by the Fund incidental to its main investment strategy. The Sub Adviser considers emerging market countries to be those included in the Funds benchmark index, the MSCI Emerging Markets Index; countries determined by the World Bank to have a low to middle income economy and other countries or markets with similar emerging market characteristics as determined by the Sub Adviser. A company is considered to be located in an emerging market country if it has a class of securities whose principal securities market is in an emerging market country; is organized under the laws of, or has a principal office in, an emerging market country; derives 50% or more of its total revenues or earnings from goods produced, sales made, or services provided in one or more emerging market countries; or maintains 50% or more of its assets in one or more emerging market countries. The Fund may invest in companies of any market capitalization but seeks to have market capitalization size characteristics similar to that of the MSCI Emerging Markets Index. As of December 31, 2019, the market capitalization of the MSCI Emerging Markets Index companies ranged from $104.0 million to $358.9 billion with a weighted average market capitalization of $66.9 billion. The Fund is expected to invest its assets among companies located in emerging markets throughout the world. The Fund may also invest in securities denominated in foreign currencies and may acquire foreign currency or enter into foreign currency derivatives (including forward foreign currency exchange contracts and currency futures contracts) to seek to hedge foreign currency exposure. Securities of companies located in emerging market countries may include American Depositary Receipts (ADRs), which may be sponsored or unsponsored, and Global Depositary Receipts (GDRs).
|Asset Type||% Of Allocation|
|Total Net Assets||190.99 M|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$0|
|Timeframe||Average Annual Current Performance Monthly As Of 09/30/2021||Average Annual Current Performance Quarterly As Of 09/30/2021||Avg Annual Current Performance Monthly As Of 09/30/2021||Avg Annual Current Performance Quarterly As Of 09/30/2021|
|Life Of Fund||
|Symbol||Company Name||% Of Assets|
|NSRGY||NESTLE SA SPONS ADR FOR REG||5.04%|
|ASML||ASML HOLDING NV||2.96%|
|NVO||NOVO NORDISK A/S SPONS ADR||2.86%|
|SCHN.PA||SCHNEIDER ELECTRIC SA||2.82%|
Master The Market with the Help of Our Financial Experts
Solid third quarters continue to power stocks higher Tuesday, even as growth and inflation signals remain stubbornly persistent as oil prices top $85 a barrel in overnight trading.
Procter & Gamble held its 2022 forecasts in place, seeing sales growth of between 2% and 4%, following stronger-than-expected first quarter earnings.
Johnson & Johnson said it sees 2021 vaccine sales of $2.5 billion, with overall revenues rising to between $94.1 billion to $94.6 billion, following its Q# earnings beat.
Stocks edge higher ahead of earnings; SEC says GameStop surge powered by believers; FDA set to approve "mix & match' COVID boosters; DraftKings faces Entain bid deadline and Rent the Runway seeks $1.3 billion valuation in Nasdaq IPO.